JP2023123726A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023123726A5 JP2023123726A5 JP2023105929A JP2023105929A JP2023123726A5 JP 2023123726 A5 JP2023123726 A5 JP 2023123726A5 JP 2023105929 A JP2023105929 A JP 2023105929A JP 2023105929 A JP2023105929 A JP 2023105929A JP 2023123726 A5 JP2023123726 A5 JP 2023123726A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- hvr
- amino acid
- acid sequence
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017091955 | 2017-05-02 | ||
| JP2017091955 | 2017-05-02 | ||
| PCT/JP2018/017495 WO2018203567A1 (en) | 2017-05-02 | 2018-05-02 | Cytotoxicity-inducing therapeutic agent |
| JP2019559378A JP2020518584A (ja) | 2017-05-02 | 2018-05-02 | 細胞傷害誘導治療剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019559378A Division JP2020518584A (ja) | 2017-05-02 | 2018-05-02 | 細胞傷害誘導治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023123726A JP2023123726A (ja) | 2023-09-05 |
| JP2023123726A5 true JP2023123726A5 (esLanguage) | 2025-08-05 |
Family
ID=64016153
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019559378A Pending JP2020518584A (ja) | 2017-05-02 | 2018-05-02 | 細胞傷害誘導治療剤 |
| JP2023105929A Withdrawn JP2023123726A (ja) | 2017-05-02 | 2023-06-28 | 細胞傷害誘導治療剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019559378A Pending JP2020518584A (ja) | 2017-05-02 | 2018-05-02 | 細胞傷害誘導治療剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20200123256A1 (esLanguage) |
| EP (1) | EP3619238A4 (esLanguage) |
| JP (2) | JP2020518584A (esLanguage) |
| WO (1) | WO2018203567A1 (esLanguage) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3434767T3 (fi) | 2010-11-30 | 2026-02-12 | Chugai Seiyaku Kk | Sytotoksisuutta aiheuttava terapeuttinen aine |
| JP6371059B2 (ja) | 2011-10-31 | 2018-08-08 | 中外製薬株式会社 | 重鎖と軽鎖の会合が制御された抗原結合分子 |
| TWI726842B (zh) | 2014-04-07 | 2021-05-11 | 日商中外製藥股份有限公司 | 免疫活化抗原結合分子 |
| SG11201609370QA (en) | 2014-05-13 | 2016-12-29 | Chugai Pharmaceutical Co Ltd | T cell-redirected antigen-binding molecule for cells having immunosuppression function |
| WO2017086419A1 (ja) | 2015-11-18 | 2017-05-26 | 中外製薬株式会社 | 液性免疫応答の増強方法 |
| JP6931329B2 (ja) | 2015-11-18 | 2021-09-01 | 中外製薬株式会社 | 免疫抑制機能を有する細胞に対するｔ細胞リダイレクト抗原結合分子を用いた併用療法 |
| BR112018009312A8 (pt) | 2015-12-28 | 2019-02-26 | Chugai Pharmaceutical Co Ltd | método para promover eficiência de purificação de polipeptídeo contendo região de fc |
| US11993645B2 (en) | 2017-01-11 | 2024-05-28 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions comprising R-Spondin (RSPO) surrogate molecules |
| WO2018140821A1 (en) | 2017-01-26 | 2018-08-02 | Surrozen, Inc. | Tissue-specific wnt signal enhancing molecules and uses thereof |
| US12466884B2 (en) | 2018-07-09 | 2025-11-11 | Surrozen Operating, Inc. | Tissue-specific WNT signal enhancing molecules and uses |
| MX2022000111A (es) | 2019-07-10 | 2022-02-10 | Chugai Pharmaceutical Co Ltd | Moleculas de union a claudina-6 y usos de las mismas. |
| US12454580B2 (en) | 2020-04-10 | 2025-10-28 | Regeneron Pharmaceuticals, Inc. | FRB antibodies |
| CN112175080B (zh) * | 2020-10-22 | 2021-05-25 | 优睿赛思(武汉)生物科技有限公司 | 抗人白介素-6高亲和力兔单克隆抗体及应用 |
| EP4243878A4 (en) | 2020-11-16 | 2025-05-14 | Surrozen Operating, Inc. | Liver-specific WNT signal-enhancing molecules and their uses |
| EP4288458A1 (en) * | 2021-02-03 | 2023-12-13 | Genentech, Inc. | Multispecific binding protein degrader platform and methods of use |
| JP2025508949A (ja) * | 2022-02-28 | 2025-04-10 | アデプト セラピューティクス インコーポレイテッド | 抗プログラム細胞死リガンド１（ｐｄ－ｌ１）抗体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20240939T1 (hr) * | 2013-12-17 | 2024-10-25 | Genentech, Inc. | Anti-cd3 protutijela i metode uporabe |
| AU2015249887A1 (en) * | 2014-04-21 | 2016-11-03 | Abbvie Stemcentrx Llc | Novel anti-RNF43 antibodies and methods of use |
| MA40764A (fr) * | 2014-09-26 | 2017-08-01 | Chugai Pharmaceutical Co Ltd | Agent thérapeutique induisant une cytotoxicité |
| JP2018520642A (ja) * | 2015-05-01 | 2018-08-02 | ジェネンテック， インコーポレイテッド | マスク抗ｃｄ３抗体及びその使用方法 |
-
2018
- 2018-05-02 US US16/605,556 patent/US20200123256A1/en not_active Abandoned
- 2018-05-02 EP EP18794608.2A patent/EP3619238A4/en active Pending
- 2018-05-02 JP JP2019559378A patent/JP2020518584A/ja active Pending
- 2018-05-02 WO PCT/JP2018/017495 patent/WO2018203567A1/en not_active Ceased
-
2023
- 2023-06-28 JP JP2023105929A patent/JP2023123726A/ja not_active Withdrawn
- 2023-12-11 US US18/535,310 patent/US20240239890A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023123726A5 (esLanguage) | ||
| JP2019502712A5 (esLanguage) | ||
| JP2022031635A5 (esLanguage) | ||
| JP2020180158A5 (esLanguage) | ||
| JP2023134618A5 (esLanguage) | ||
| JP2018522541A5 (esLanguage) | ||
| CN115702008A (zh) | 抗体药物偶联物 | |
| JP2018108081A5 (esLanguage) | ||
| JP2017514461A5 (esLanguage) | ||
| JP2017534577A5 (esLanguage) | ||
| JP2023116744A5 (esLanguage) | ||
| JP2019513701A5 (esLanguage) | ||
| JP2020525032A5 (esLanguage) | ||
| JP2020531438A5 (ja) | Ｎｋｇ２ｄ、ｃｄ１６、およびｈｌａ−ｅに結合するタンパク質 | |
| JP2018527887A5 (esLanguage) | ||
| FI4141032T3 (fi) | T-solua aktivoivien bispesifisten antigeeniä sitovien molekyylien ja pd-1-akselia sitovien antagonistien yhdistelmähoito | |
| HRP20240939T1 (hr) | Anti-cd3 protutijela i metode uporabe | |
| JP2020502233A5 (esLanguage) | ||
| JPWO2019204564A5 (esLanguage) | ||
| FI3452515T3 (fi) | HER-2 sitoutuvia vasta-aineita | |
| JPWO2018206790A5 (esLanguage) | ||
| JPWO2020033664A5 (esLanguage) | ||
| JPWO2022044573A5 (esLanguage) | ||
| JP2023103352A5 (esLanguage) | ||
| JPWO2023034922A5 (esLanguage) |